AI & Biomanufacturing: The Future of Drug Production-(Ep #196)

Reza explores how artificial intelligence is revolutionizing biomanufacturing—streamlining drug production, scaling organic materials, and making biotech more sustainable and accessible worldwide.About the Episode:Welcome back to the Future Tech & Foresight podcast. I’m your AI host Marc Vernkov’s Deepfake avatar—and this is episode number 196.In this episode, Marc is joined by Reza, an expert in biomanufacturing who unpacks the crucial differences between chemical and biological production—using organisms instead of labs to grow complex therapeutics like Ozempic or Keytruda. They trace the evolution of biotech from early penicillin breakthroughs to the modern plateau of inefficient, trial-and-error systems.Reza explains how AI and automation can dramatically speed up and improve these processes, reducing drug costs, accelerating time-to-market, and unlocking new forms of organic materials—including sustainable meat, milk, and leather. From genetic optimization to global scaling—this is a thought-provoking look at how AI promises to reshape biology and the future of manufacturing.About the Guest:Reza is a third-time founder with two successful exits, reflecting his strong track record in launching and scaling technology ventures. Before founding Katalyze AI, he gained strategic consulting experience at BCG, where he focused on driving data-driven solutions for diverse industries. He holds a Master’s degree in System Design Engineering from the University of Waterloo. His leadership establishes the company as a trusted partner in Biomanufacturing.Website: https://katalyzeai.com/ Linkedin: https://www.linkedin.com/in/reza-farahani-/Timestamps:00:00:55 - Episode Commences00:02:27 - Chemical vs. Biological Manufacturing Differences 00:06:03 - Biomanufacturing Complexity and Optimization Challenges 00:08:16 - Biomanufacturing of Penicillin: Early Challenges 00:11:00 - AI Revolutionizing Biomanufacturing and Organic Materials 00:16:45 - Optimizing Microorganism Performance With Genetic Analysis00:19:03 - Optimizing Drug Manufacturing for Accessibility 00:23:11 - AI's Potential to Reduce Commercialization Period00:25:17 - AI and Automation in Biomanufacturing00:43:22 - Episode ConcludesAdditional Notes:For more check out the website: https://futuretechandforesight.com/Or connect with me on –Twitter: https://twitter.com/FutureTech_PodLinkedin: https://www.linkedin.com/company/futuretechandforesight/